Welcome to our dedicated page for BRASKEM SA SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRASKEM SA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRASKEM SA's regulatory disclosures and financial reporting.
BRASKEM SA filed an initial insider ownership report for M. P. de A. Brandao Carlos A., who serves as CFO and Investor Relations Officer. This filing establishes the executive as a reporting person but shows no reportable equity transactions or derivative positions in the available data.
Braskem S.A. held an extraordinary board meeting that ended the terms of its prior statutory officers ahead of schedule and appointed a new executive team. Helcio Tokeshi was elected Chief Executive Officer, while Carlos Augusto Machado Pereira de Almeida Brandão became Chief Financial Officer and Investor Relations Officer, alongside new Chief Transformation and Chief Legal Officers and the re-election of several Petrobras-nominated officers for a two-year term ending after the board meeting following the 2027 annual shareholder meeting.
The board also formalized detailed delegation and approval limits for the Executive Board covering loans, guarantees, asset transactions, investments, related‑party contracts and legal settlements. These rules set specific monetary thresholds for decisions taken individually by officers versus collectively by the Executive Board and those that must escalate to the Board of Directors.
BRASKEM SA filed a Form 3 to report that Walter Susini is now an insider as a director of the company. The filing does not list any current holdings, option grants, or recent transactions in BRASKEM SA securities, and serves mainly as an initial ownership disclosure required by regulators.
BRASKEM SA director Octavio Cortes Pereira Lopes has filed an initial Form 3 reporting his status as an insider of the company. This filing identifies him as a director of BRASKEM SA but, in this excerpt, does not show any reported buy, sell, or other share transactions.
BRASKEM SA executive Luiz Gustavo Perrotti Rossato has filed an initial Form 3 as Chief Transformation Officer. This Form 3 is an initial statement of beneficial ownership and, based on the available data, does not report any share transactions or derivative holdings in this filing.
Braskem SA director Luciano Galvao Coutinho has filed an initial Form 3 reporting his status as an insider of the company. The filing lists him as a director of Braskem SA but does not report any share transactions, option exercises, or other insider trades at this time.
BRASKEM SA filed an initial ownership report (Form 3) for Helcio Tokeshi, who serves as Chief Executive Officer. The filing establishes his status as an officer and indicates he is not listed as a ten percent owner. No insider transactions are reported in this filing.
BRASKEM SA filed an initial Form 3 for Camilla Tedeschi de Toledo Tapias, who serves as Chief Legal Officer. This filing establishes her status as a reporting officer of the company. The data provided show no reported share holdings or transactions at this time.
Braskem S.A. filed a Form 6-K outlining updated internal rules for its Executive Officers Board. The Executive Board will consist of eight statutory officers, including the Chief Executive Officer, Chief Financial and Investor Relations Officer and other key functional leaders, each serving a two-year term with re-election permitted.
The rules formalize how the Board is composed, how officers are replaced, and how decisions are made, including requiring meetings at least once every fortnight and setting detailed procedures for agendas, quorum and voting. They also clarify prohibited actions, conflict-of-interest handling, minutes and disclosure practices, annual performance evaluation, and onboarding and succession processes. These internal rules were approved by the Board of Directors on June 8, 2026 and will be made available on the company’s website.
Braskem S.A. adopted detailed internal regulations for its Compliance and Audit Committee (CAE), approved by the Board of Directors on June 8, 2026. The CAE is a permanent advisory body to the Board, covering compliance, internal controls, internal audit, risk management, anti-corruption and related governance topics.
The rules define a five-member committee with a two-year term, majority independence under CVM Resolution 23/21, at least one financial expert, and an external independent coordinator. They also formalize the role of the Compliance and Conformity Officer, minimum meeting frequency, executive sessions with auditors, conflict-of-interest handling, remuneration principles and strict confidentiality and document-management requirements.